US Lymphedema Treatment Market: Has the 2024 Policy Shift Finally Unlocked Universal Access?
The US Lymphedema Treatment Market is hitting its stride in 2026, largely thanks to the long-term impact of the Lymphedema Treatment Act and subsequent Medicare policy shifts that now classify compression garments as "medically necessary." This has moved thousands of patients from "self-pay" to "covered" status, unlocking massive pent-up demand and driving the global Lymphedema Treatment Market...
0 Commenti 0 condivisioni 31 Views 0 Anteprima
Lifesone https://lifesone.com